U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
126511126511PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.TerminatedNo Results AvailableHIV InfectionsDrug: TMC589337, TMC589354, TMC310911, placebohttps://ClinicalTrials.gov/show/NCT00908414
126512126512Analgesic Effect of Breastmilk for Procedural Pain in Preterm InfantsRecruitingNo Results AvailableProcedural PainOther: Breastmilk|Other: Oral Sucrosehttps://ClinicalTrials.gov/show/NCT00908401
126513126513Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic DissectionActive, not recruitingHas ResultsType B Aortic DissectionDevice: GORE TAG® Thoracic Endoprosthesishttps://ClinicalTrials.gov/show/NCT00908388
126514126514Efficacy of Pregabalin in Patients With Radicular PainCompletedHas ResultsNeuropathy; Radicular, Lumbar, Lumbosacral|Failed Back Surgery Syndrome|Spinal Stenosis|Herniated DiscDrug: Pregabalin|Drug: Sugar Pillhttps://ClinicalTrials.gov/show/NCT00908375
126515126515Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in SmokersCompletedNo Results AvailableSmoke-related Lung Diseases|Chronic Obstructive Pulmonary DiseaseDrug: fluticasone|Drug: fluticasone/salmeterol|Drug: placebohttps://ClinicalTrials.gov/show/NCT00908362
126516126516Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyCompletedNo Results AvailablePartial EpilepsyDrug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT00908349
126517126517Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy RegimenRecruitingNo Results AvailableNon-Small Cell Lung CancerDrug: Docetaxel and Erlotinib|Drug: Erlotinibhttps://ClinicalTrials.gov/show/NCT00908336
126518126518Early Immune Responses to Vaccination - A Substudy to HVTN 205CompletedNo Results AvailableHIV InfectionsBiological: JS7 DNA vaccine|Biological: MVA/HIV62 vaccinehttps://ClinicalTrials.gov/show/NCT00908323
126519126519Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)CompletedHas ResultsChronic Kidney Disease|Renal InsufficiencyDrug: Omniscanhttps://ClinicalTrials.gov/show/NCT00908310
126520126520Safety and Tolerability of Coenzyme Q10 in Hemodialysis PatientsCompletedNo Results AvailableCardiovascular Disease|End Stage Renal Disease|Atherosclerosis|Oxidative StressDietary Supplement: Coenzyme Q10https://ClinicalTrials.gov/show/NCT00908297
126521126521Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIVRecruitingNo Results AvailableHIV|Acquired Immunodeficiency Syndrome|Cardiovascular DiseasesBehavioral: Exercise Program|Behavioral: Control Grouphttps://ClinicalTrials.gov/show/NCT00908284
126522126522Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy SubjectsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Dapagliflozinhttps://ClinicalTrials.gov/show/NCT00908271
126523126523Ischemic Preconditioning in Major HepatectomyCompletedNo Results AvailableIschaemic Type Biliary LesionProcedure: Control|Procedure: Preconditioning ischemiahttps://ClinicalTrials.gov/show/NCT00908245
126524126524Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VDCompletedHas ResultsMultiple MyelomaDrug: Cyclophosphamide|Drug: Bortezomib|Drug: Dexamethasone|Drug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT00908232
126525126525A Study of Bevacizumab to Prevent Malignant AscitesWithdrawnNo Results AvailableMalignant AscitesDrug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00908219
126526126526Effects of GSK598809 on Brain Activation in Abstinent AlcoholicsWithdrawnNo Results AvailableSubstance Dependence|Alcohol DependenceDrug: GSK598809https://ClinicalTrials.gov/show/NCT00908206
126527126527Laparoscopic "DA VINCI" Robot Assisted Abdominal Wall Hernia RepairCompletedNo Results AvailableAbdominal Wall HerniaDevice: Laparoscopic DA VINCI Robot Assisted coelioscopy|Procedure: conventional coelioscopyhttps://ClinicalTrials.gov/show/NCT00908193
126528126528Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaNot yet recruitingNo Results AvailableLymphomaBiological: alemtuzumab|Biological: donor lymphocytes|Drug: carmustine|Drug: cyclosporine|Drug: cytarabine|Drug: etoposide|Drug: melphalan|Procedure: allogeneic hematopoietic stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00908180
126529126529Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic MalignanciesCompletedNo Results AvailableAcute Myeloid Leukemia|Infantile Leukemia (Both AML and ALL)|Myelodysplastic Syndrome|Myelodysplastic/Myeloproliferative Neoplasms|Biphenotypic LeukemiaDrug: Sorafenib|Drug: Cytarabine|Drug: Clofarabinehttps://ClinicalTrials.gov/show/NCT00908167
126530126530Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.CompletedNo Results AvailableBipolar Depression|Bipolar DisorderDrug: Placebo|Drug: GSK1014802https://ClinicalTrials.gov/show/NCT00908154
126531126531GM-CSF in Treating Patients With Relapsed Prostate CancerCompletedHas ResultsProstate CancerBiological: sargramostimhttps://ClinicalTrials.gov/show/NCT00908141
126532126532Mycophenolate Mofetil Tablets Under Fed ConditionsCompletedHas ResultsHealthyDrug: Mycophenolate Mofetil|Drug: CellCept®https://ClinicalTrials.gov/show/NCT00908128
126533126533Post Market Surveillance for Infanrixâ„¢CompletedHas ResultsDiphteria, Tetanus and PertussisBiological: GSK Biologicals' Infanrixâ„¢https://ClinicalTrials.gov/show/NCT00908115
126534126534Managing Non-acute Low Back Symptoms in Occupational Health: Two TrialsActive, not recruitingNo Results AvailableLow Back Pain, Recurrent|Low Back PainOther: Moderate|Other: Mild|Other: Mild vs. NC|Other: Moderate vs. NChttps://ClinicalTrials.gov/show/NCT00908102
126535126535TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid ArthritisActive, not recruitingNo Results AvailableRheumatoid ArthritisDrug: Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab|Drug: Trexan+Salazopyrin+Oxiklorin+prednisolone + placebohttps://ClinicalTrials.gov/show/NCT00908089
126536126536Amitiza in Constipation Associated With PD (Parkinson's Disease)CompletedNo Results AvailableParkinson's DiseaseDrug: LUBIPROSTONEhttps://ClinicalTrials.gov/show/NCT00908076
126537126537Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI)TerminatedNo Results AvailableTraumatic Brain InjuryDrug: Oxycyte|Drug: Normal Salinehttps://ClinicalTrials.gov/show/NCT00908063
126538126538Study of the Safety and Efficacy of Botox in BruxismRecruitingNo Results AvailableBruxismDrug: Botulinum toxin type Ahttps://ClinicalTrials.gov/show/NCT00908050
126539126539Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedHas ResultsPurpura, Thrombocytopaenic, IdiopathicDrug: eltrombopag|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00908037
126540126540Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid TumorsTerminatedNo Results AvailableColorectal Cancer|Head and Neck Cancer|Neoplasm MetastasisDrug: BMS-754807|Drug: cetuximab (Erbitux®)https://ClinicalTrials.gov/show/NCT00908024

* Görseller ve İçerik tekif hakkına sahip olabilir